The Next Era
in Drug Discovery
Nextera is a drug and target discovery company
We are offering a unique and novel approach for improved therapeutic intervention in the major disease areas autoimmunity, chronic inflammatory disorders and cancer
Our approach is to modulate the disease at the core of the escalating immune cascade translating to disease-specific treatment without compromising systemic immunity
About us
Nextera is spun out from a world class Centre of Excellence research environment at the University of Oslo and Oslo University Hospital
Our technology
NextCore mimics the pivotal interaction between Antigen Presenting Cells (APC) and T helper cells (Th)